Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	89	112	71	106	197	128	108
Market Cap Growth	-	57.54%	-32.42%	-46.38%	53.54%	18.98%	-
Enterprise Value	73	96	62	98	183	121	81
PE Ratio	-120.07	-120.07	-7.91	-53.99	-7.04	-7.00	-2.89
PS Ratio	2.71	3.44	3.12	4.52	5047.59	133.69	-
PB Ratio	5.72	7.26	5.46	5.99	12.57	12.15	4.10
P/FCF Ratio	12.99	16.49	14.91	-26.19	-8.79	-6.70	-12.86
P/OCF Ratio	12.99	16.49	14.80	-22.36	-8.81	-7.11	-13.23
EV/Sales Ratio	2.22	2.95	2.69	4.19	4684.69	125.87	-
EV/EBITDA Ratio	-331.26	-331.26	-9.49	-200.92	-6.90	-6.65	-6.31
EV/EBIT Ratio	-80.87	-80.87	-7.45	-103.11	-6.74	-6.49	-6.28
EV/FCF Ratio	10.64	14.14	12.87	-24.28	-8.16	-6.31	-9.67
Debt / Equity Ratio	0.35	0.35	0.50	0.38	0.46	0.43	-
Debt / EBITDA Ratio	-18.56	-18.56	-1.01	-13.75	-0.27	-0.25	-
Debt / FCF Ratio	0.79	0.79	1.36	-1.66	-0.32	-0.24	-
Quick Ratio	1.53	1.53	2.81	4.36	5.63	6.39	13.21
Current Ratio	1.65	1.65	3.10	5.18	6.51	7.65	13.59
Asset Turnover	1.11	1.11	0.99	0.81	0.00	0.05	0
Interest Coverage	-	-	-10.85	-0.94	-31.56	-	-
Return on Equity (ROE)	-6.20%	-6.20%	-70.90%	-10.30%	-322.40%	-124.50%	-383.20%
Return on Assets (ROA)	-3.20%	-3.20%	-38.90%	-6.80%	-160.90%	-102.00%	-178.30%
Return on Capital (ROIC)	-0.92%	-0.92%	-33.77%	0.02%	-118.88%	-123.11%	-39.24%
Earnings Yield	-1.06%	-0.83%	-12.65%	-1.85%	-14.21%	-14.29%	-34.55%
FCF Yield	7.70%	6.06%	6.70%	-3.82%	-11.38%	-14.91%	-7.78%
Buyback Yield / Dilution	-1.98%	-1.98%	0.24%	-19.98%	-18.29%	-176.74%	-
Total Shareholder Return	-1.98%	-1.98%	0.24%	-19.98%	-18.29%	-176.74%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).